Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

V. Oddis, Chester; M. Reed, Ann; Aggarwal, Rohit; G. Rider, Lisa; P. Ascherman, Dana; C. Levesque, Marc; J. Barohn, Richard; M. Feldman, Brian; O. Harris‐Love, Michael; Koontz, Diane; Fertig, Noreen; Kelley, Stephanie; L. Pryber, Sherrie; W. Miller, Frederick; E. Rockette, Howard; the RIM Study Group, and

doi:10.1002/art.37754

Public

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

Published in Arthritis & Rheumatism • Nov 2, 2012

Authors:

Chester V. Oddis

Ann M. Reed

Rohit Aggarwal

Abstract

OBJECTIVE: To assess the safety and efficacy of rituximab in a randomized, double-blind, placebo-phase trial in adult and pediatric myositis patients. METHODS: Adults with refractory polymyositis (PM) and adults and children with refractory dermatomyositis (DM) were enrolled. Entry criteria included...

Subject

Rituximab

Medicine

Juvenile dermatomyositis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!